PINCH-1 inhibitors constitute a class of chemical compounds designed to target and modulate the activity of the PINCH-1 protein, which is a crucial component of cellular adhesion and signaling pathways. PINCH-1, short for particularly interesting Cys-His-rich protein 1, is part of a protein complex that includes Integrin-Linked Kinase (ILK) and Parvin. This complex plays a central role in various cellular processes, including cell adhesion, migration, proliferation, and cytoskeletal organization. PINCH-1 itself is characterized by its LIM (Lin-11, Isl-1, and Mec-3) domain, which facilitates protein-protein interactions.The mechanisms of PINCH-1 inhibitors typically involve disrupting the formation or stability of the PINCH-1-ILK-Parvin complex. Many inhibitors specifically target the interaction between PINCH-1 and ILK, preventing the formation of this complex. By doing so, they hinder downstream signaling cascades that rely on the complex's integrity.
PINCH-1 inhibitors may directly bind to the LIM domain of PINCH-1, interfering with its ability to interact with other proteins or substrates. These compounds are designed to exert a regulatory influence over PINCH-1-related cellular processes, such as the control of integrin-mediated signaling and focal adhesion dynamics. By selectively inhibiting PINCH-1, these compounds offer valuable tools for researchers to explore the roles of PINCH-1 in cellular functions and gain insights into the underlying molecular mechanisms. PINCH-1 inhibitors are a class of chemical compounds developed to perturb the function of the PINCH-1 protein and its associated signaling complex. These inhibitors are instrumental in deciphering the intricate cellular processes controlled by PINCH-1, shedding light on its contributions to cell adhesion, migration, and signaling pathways. Understanding the mechanisms of action of PINCH-1 inhibitors provides valuable insights into the fundamental biology of cell adhesion and may have potential applications in various research fields.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PRT4165 | 31083-55-3 | sc-507487 | 10 mg | $134.00 | ||
PRT-4165 is a small molecule inhibitor that disrupts the interaction between PINCH-1 and ILK (Integrin-Linked Kinase), thereby inhibiting the formation of the PINCH-1-ILK-Parvin complex. This disruption interferes with cell adhesion, migration, and signaling pathways related to integrin-mediated processes. | ||||||
CCG-1423 | 285986-88-1 | sc-205241 sc-205241A | 1 mg 5 mg | $30.00 $90.00 | 8 | |
CCG-1423 selectively targets the LIM domain of PINCH-1, preventing its association with other proteins. This disruption impairs integrin-mediated signaling and focal adhesion assembly, leading to decreased cell migration and invasion. | ||||||
Cilengitide | 188968-51-6 | sc-507335 | 5 mg | $215.00 | ||
Cilengitide is an RGD-mimetic peptide that inhibits integrin receptors, including those associated with PINCH-1. By interfering with integrin-mediated signaling, it suppresses cell adhesion, migration, and angiogenesis. | ||||||
FAK Inhibitor 14 | 4506-66-5 | sc-203950 sc-203950A | 10 mg 50 mg | $109.00 $238.00 | 86 | |
FAK Inhibitor 14 targets Focal Adhesion Kinase (FAK), which interacts with PINCH-1. By inhibiting FAK, it indirectly disrupts PINCH-1-mediated signaling pathways involved in cell adhesion and migration. | ||||||
E7820 | 289483-69-8 | sc-507333 | 10 mg | $102.00 | ||
E7820 targets angiogenesis and disrupts various signaling pathways, including those involving PINCH-1. Its mechanism of action involves suppressing endothelial cell migration and vessel formation. | ||||||